Skip to content
The Policy VaultThe Policy Vault

biologic immunomodulator agents — Blue Cross Blue Shield of Illinois

chronic severe plaque psoriasis (PS)

Initial criteria

  • The patient has a diagnosis of chronic severe plaque psoriasis (PS).

Approval duration

12 months